Where to Inject KLOW: Injury Site and Rotation
KLOW carries a placement instruction most peptides do not: the dose goes as close to the injury site as possible. Four peptides share one vial, and you still have to rotate. Here is how those two instructions fit together in practice.

In this article
Key Takeaways
- KLOW is four peptides sharing one vial: BPC-157, GHK-Cu, KPV, and TB-500, supplied at 3 mg, 10 mg, 3 mg, and 3 mg per mL.
- The prescription says to inject as close to the injury site as possible, the same placement rule BPC-157 and the BPC/TB-500 combo carry.
- Rotation still applies. Proximity chooses the body region; rotation chooses the spot inside it. Never inject into a tendon, a joint, or muscle.
- Standard dose is 20 units (0.2 mL) under the skin, Monday through Friday, run for 6 weeks and then off for 6 weeks before restarting. It is not a continuous therapy.
- No NSAIDs during use. Some people feel brief lightheadedness after a dose; sit or lie down for a few minutes until it passes.
KLOW Injection Quick Facts
Route
Subcutaneous, 20 units (0.2 mL) per injection
In the Vial
BPC-157, GHK-Cu, KPV, TB-500 at 3/10/3/3 mg per mL
Placement
As close to the injury site as possible, still rotating
Schedule
Monday through Friday, weekends off
Cycle
6 weeks on, then 6 weeks off before restarting
Storage
Refrigerated 36-46°F, upright, do not freeze
KLOW Is Four Peptides in One Vial
Where to inject KLOW comes with an instruction most of the PeRx catalog does not carry: put it as close to the injury site as possible. BPC-157 and the BPC/TB-500 combo say the same thing, and KLOW is the four-peptide version of that idea. The route itself is nothing unusual. It is a subcutaneous injection, 20 units under the skin, five days a week, using the same short insulin syringe as everything else. What changes is how you choose the spot. Rather than defaulting to the abdomen because it is the easiest place to reach, you start from the area you are trying to support and work outward to the nearest region that can safely take a needle. If you have never given yourself a subQ shot, read our walkthrough on injecting peptides first, then come back for the part that is specific to this blend. One thing you will not have to deal with: PeRx ships KLOW fully reconstituted and ready to use, so there is no powder, no mixing, and no measuring beyond drawing 0.2 mL out of the vial.
The vial holds four peptides at once, which is unusual even by combination-product standards. BPC-157 and TB-500 are the familiar recovery pair, and the BPC-157/TB-500 guide explains why they are almost always run together rather than alone. GHK-Cu is the copper peptide with the deepest research record in skin and connective tissue; the GHK-Cu guide covers that background. KPV is the component most people have never heard of. It is a three-amino-acid fragment of alpha-MSH that acts on inflammatory signaling without the pigmentation activity of the parent molecule. Four peptides, one 5 mL vial, one injection a day instead of four.
Where to Inject KLOW: The Four Standard Regions
Every subcutaneous peptide uses the same four areas of the body, and KLOW is no exception. The difference is that with most peptides you pick one and stay there. With KLOW, the injury decides for you. Here is the inventory you are choosing from.
Abdomen. The band between the lower ribs and the hip bones, staying at least two inches clear of the navel. Fat coverage here is usually the most forgiving of the four, and you can see exactly what you are doing without a mirror. This is the fallback whenever no region sits close to the problem area.
Front or outer thigh. The middle third of the thigh, on the front or the outside. Comfortable to reach sitting down, which matters more with KLOW than with most peptides. Stay off the inner thigh, which runs more vascular, and keep clear of the knee and the hip crease.
Upper outer glute. The upper outer quadrant of the buttock. It carries the deepest fat pad of the four regions, which makes it forgiving, but it is awkward to reach alone. A mirror helps. This is the natural region for anything going on in the low back, hip, or glute itself.
Back of the deltoid. The soft pad behind the upper arm, just past the deltoid muscle. Whether this region is usable at all depends on your build. Pinch it first. If you can gather a half inch of skin and fat, it works. If the skin pulls tight over muscle, cross it off and use something else.
Injury Proximity vs Rotation
Two instructions arrive at the same time and they sound like they contradict each other. The prescription says to inject as close to the injury site as possible. Standard injection technique says never to hit the same spot twice in a row. Patients call about this in the first week, and the answer is simpler than it looks: the two rules operate at different scales. Proximity picks the region. Rotation picks the spot inside that region.
Work in that order. Find the standard subQ region closest to the area you are trying to support, and confirm you can pinch a real fold of skin and fat there. That region becomes home base. Then rotate within it exactly the way you would anywhere else: move at least a finger-width from yesterday, work through the available spots in a fixed order rather than at random, and let several days pass before any single spot repeats. Five injections a week means you need roughly five usable spots. Most regions have that and then some. The abdomen alone has eight if you split each side of the navel into quadrants.
Matching a problem area to a region is usually obvious once you say it out loud. Shoulder, rotator cuff, or elbow: back of the deltoid on that side, assuming the fat pad is there to pinch. Knee, quad, hamstring, or calf: the front or outer thigh of that leg, mid-thigh, well above the knee. Low back, hip, or glute: the upper outer glute on the affected side. Gut, core, or abdominal wall: the abdomen, two inches or more from the navel.
The awkward cases are the extremities. Ankles, Achilles tendons, wrists, hands, and feet have almost no subcutaneous fat, and there is no version of this protocol where you inject into one of them. Move up the limb to the nearest region that can actually take a subQ injection. A lower-leg problem gets the thigh. A wrist or hand problem gets the back of the arm, or the abdomen if the arm is too lean. Closer is better, but only among sites that are safe to begin with.
Subcutaneous Only
KLOW goes into the fat layer under the skin. Never into a tendon, never into a joint capsule, never into muscle. If the only tissue over the sore area is skin stretched across bone or tendon, that area is not an injection site. Pick the nearest region with a pinchable fold instead.
Practical Default
Choose the region nearest the injury on Monday and stay in it all week, moving a finger-width each day. If nothing sits close to the problem area, or the closest region is too lean to pinch, use the abdomen and rotate normally. A dose given in a good site beats a dose forced into a bad one.
What Each Injection Delivers
One 20-unit injection carries 3.8 mg of peptide in total, split unevenly across the four components. GHK-Cu accounts for more than half of it by weight, which is why the solution behaves the way it does and why the copper peptide dominates the volume math. The rest is divided evenly.
| Component | Per mL | Per 20-unit dose | What it contributes |
|---|---|---|---|
| BPC-157 | 3 mg | 0.6 mg | Angiogenesis and growth-factor recruitment; the localized repair-support component and the reason placement matters |
| GHK-Cu | 10 mg | 2.0 mg | Copper peptide signaling for collagen and elastin synthesis; supports skin and connective tissue remodeling |
| KPV | 3 mg | 0.6 mg | Tripeptide fragment of alpha-MSH; acts on inflammatory signaling without the pigmentation activity of the parent molecule |
| TB-500 | 3 mg | 0.6 mg | Actin upregulation supporting cell migration and whole-body recovery rather than one location |
| Total | 19 mg | 3.8 mg | Four peptides delivered in a single 0.2 mL subcutaneous shot |
BPC-157
- Per mL
- 3 mg
- Per 20-unit dose
- 0.6 mg
- What it contributes
- Angiogenesis and growth-factor recruitment; the localized repair-support component and the reason placement matters
GHK-Cu
- Per mL
- 10 mg
- Per 20-unit dose
- 2.0 mg
- What it contributes
- Copper peptide signaling for collagen and elastin synthesis; supports skin and connective tissue remodeling
KPV
- Per mL
- 3 mg
- Per 20-unit dose
- 0.6 mg
- What it contributes
- Tripeptide fragment of alpha-MSH; acts on inflammatory signaling without the pigmentation activity of the parent molecule
TB-500
- Per mL
- 3 mg
- Per 20-unit dose
- 0.6 mg
- What it contributes
- Actin upregulation supporting cell migration and whole-body recovery rather than one location
Total
- Per mL
- 19 mg
- Per 20-unit dose
- 3.8 mg
- What it contributes
- Four peptides delivered in a single 0.2 mL subcutaneous shot
Two of these four are systemic by nature. TB-500 distributes and works wherever cells are migrating, and GHK-Cu circulates the same way. Proximity is not doing much for those. It is BPC-157, and to a lesser degree KPV, that gives the placement instruction its logic, since local tissue concentration is highest near where the needle went in. That is the honest version: injecting near the injury is a reasonable preference backed by how one or two of the components behave, not a switch that turns the blend on or off.
Dose and the Six-Week Cycle
The standard dose is 20 units on an insulin syringe, which is 0.2 mL. A 5 mL vial holds 25 of those, so at five injections a week one vial covers five weeks and a full six-week course runs into a second vial. You inject Monday through Friday and take weekends off, so two rest days a week are built into the schedule from the start. Draw at the syringe markings, not by eye. Twenty units is a small pull, and the difference between a full dose and half of one is only a few marks on the barrel.
KLOW runs in defined courses. Six weeks on, then six weeks off before restarting if it is still needed. This is not a peptide you stay on indefinitely, and the off period is part of the protocol rather than a break you take when you remember. Put the end date in your calendar the day you start. Patients who lose track of week six are usually the same ones who never wrote it down.
No NSAIDs While You Are On KLOW
Do not take ibuprofen, naproxen, or aspirin during use. This is on your prescription, not a suggestion, and it catches people out because reaching for an anti-inflammatory is reflexive when something hurts. If you need something for pain or fever during the six weeks, contact the care team and ask what is acceptable before you open the cabinet.
What to Expect After a Dose
You may feel brief lightheadedness after injecting this blend. Sit or lie down for a few minutes and let it pass. Practically, that means doing your injection somewhere you can sit rather than standing in a bathroom, at least for the first week until you know how you react. Some patients also report a temporary metallic taste. It is occasional, it fades, and on its own it is not a cause for concern.
Contact the care team if you get a mild rash, localized hives, or injection-site irritation that does not clear within a few days. Same if a metallic taste lingers between doses rather than fading after one. And tell them if you develop a new infection or a flare of an autoimmune condition while you are on the blend, since that changes the picture in a way worth reviewing.
Call 911 for any of the following: lightheadedness that has not resolved after 15 to 20 minutes, fainting, swelling of the face, throat, or tongue, difficulty breathing, or a rapid heartbeat. These are emergency signs, not wait-and-see signs, and they warrant emergency care rather than a message to the clinic.
Storage and Handling
KLOW arrives ready to use with no reconstitution needed. Keep the vial refrigerated at 36-46°F, standing upright, and do not freeze it. Return it to the fridge after you draw rather than leaving it on the counter between doses. Give the solution a look before every injection. It carries a slight blue tint from the GHK-Cu in the blend, which is expected. If you see particles or cloudiness, stop and get in touch instead of using it. Keep the vial out of direct light, since copper peptides are oxidation-sensitive.
Traveling is fine with a little planning. Use an insulated bag with a small ice pack, keep the vial out of direct sun, and carry it on rather than checking it. Bring your prescription label or a screenshot of the order in case anyone asks. Six weeks is long enough that most people will travel at least once mid-cycle, so it is worth sorting out before the trip rather than the morning of.
Common Mistakes
Anchoring to one square inch because it is closest to the injury. This is the failure mode specific to injury-site peptides. Proximity narrows you to one region, and if you stop rotating inside it you will build a nodule within a couple of weeks and absorption will get unpredictable right where you wanted it consistent. Map five spots on day one.
Injecting into the sore structure itself. A tender tendon or a swollen joint is not a target. The needle goes into subcutaneous fat near it, never into the structure. If there is no fat over the area, move up the limb.
Standing up immediately after the shot. If lightheadedness hits, you want to already be sitting. Give it a couple of minutes before you get on with your day.
Taking ibuprofen out of habit. The no-NSAID rule applies for the whole cycle, not just injection days. Read the label on anything you take for a headache or a cold, because NSAIDs hide in combination products.
Running past six weeks because it is going well. The cycle is six on, six off. Continuing is not the protocol, and stopping on schedule is not a setback.
Reusing a syringe. Insulin syringes are single use. A second pass through a dulled needle hurts more and does more tissue damage. PeRx ships plenty with each order. The vial itself comes out of a US-based, FDA-regulated 503A compounding pharmacy and gets third-party tested before it ships.
If you are still weighing side effects before starting, the peptide side effects guide sorts the routine reactions from the ones worth a phone call.
KLOW: Common Questions
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
Where to Get Peptides in San Diego (2026 Guide)
A plain guide to peptide therapy in San Diego: what it costs across coastal clinics, med spas, and telehealth, and who tends to use it here. Plus how pharmaceutical-grade peptides reach any San Diego County address without a clinic visit.
Peptide Therapy Denver: 2026 Mountain West Guide
A plain guide to peptide therapy in Denver: what it costs across local clinics, longevity practices, and telehealth, and who tends to use it here. Plus how pharmaceutical-grade peptides reach any Colorado address, from the city to the mountain towns, without a clinic visit.
Atlanta Peptide Therapy: 2026 ATL Guide
A plain guide to peptide therapy across metro Atlanta: what it costs at clinics, med spas, and telehealth, who tends to use it here, and how pharmaceutical-grade peptides reach any Atlanta-area address without a drive across the Perimeter.
Ready to get started?
Pharmaceutical-grade KLOW, four repair peptides in a single vial, prescribed by a licensed provider and shipped to your door fully reconstituted and ready to use.
Medical Disclaimer
The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.
The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.
The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.
Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.
Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.